Compare Shell PLC (SHEL) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shell PLC vs Teladoc Health Inc — how do they compare? Shell PLC trades at $100.18 (market cap $284.34B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Shell PLC is far larger — about 281.5× Teladoc Health Inc's market cap, and Shell PLC pays a 3.12% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Shell PLC for 90 Days and Teladoc Health Inc for 39 Days on average.
| SHEL | TDOC | |
|---|---|---|
Market Cap | $284.34B | $1.01B |
Volume | 9,097,469 | 4,668,477 |
Sector | Energy | Health |
52-Week High | $100.20 | $9.72 |
52-Week Low | $70.31 | $4.47 |
Typical Hold Time | 90 Days | 39 Days |
Enterprise Value | $326.04B | $1.27B |
Dividend Yield | 3.12% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Shell (SHEL) trades at $100.20, up 3.46% today, approaching its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive earnings surprises in recent quarters. Recent developments include the approval of LNG Canada Phase 2 expansion, doubling export capacity, and strategic portfolio optimization through asset sales. Financial metrics indicate solid profitability with 8.76% net income margin and attractive valuation at P/E of 11.08.
Shell presents a compelling investment case with strong LNG growth prospects and portfolio optimization driving future cash flows. However, declining revenue trends from $381.3B in 2022 to $266.9B in 2025 and volatile energy prices pose execution risks. Analyst consensus remains bullish with $102.53 price target, though current RSI levels suggest potential near-term overbought conditions.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
